Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06802133 · ClinicalTrials.gov registry record
Post-Market Clinical Investigation Plan- Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus)
A clinical trial of Repair of Dura Mater, sponsored by Collagen Matrix.
- Recruiting
- Registry status
- 118
- Enrollment target
- 2
- Study locations
NCT06802133 is a study of Repair of Dura Mater that is actively recruiting participants, run by Collagen Matrix. The registered enrollment target is 118 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT06802133, a study of Repair of Dura Mater, is actively recruiting participants, sponsored by Collagen Matrix.
- RECRUITING
- Registry status
- 118 participants
- Enrollment target
- 2
- Study locations
Study Summary
Monitoring the Use of Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus) in the Postmarket Phase.
Conditions Studied
Interventions
- OTHER Post Market Study
Study Locations (2)
Georgia
- Augusta University - Augusta
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2025-01-13 |
| Est. Completion | 2026-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06802133
The ClinicalTrials.gov registry entry for NCT06802133 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Collagen Matrix, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Repair of Dura Mater appearing as the primary indexed condition, and to 1 intervention - of which Post Market Study is the first listed.
NCT06802133 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06802133 about?
NCT06802133 is a clinical study titled "Post-Market Clinical Investigation Plan- Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus)". Monitoring the Use of Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus) in the Postmarket Phase.
What is the current status of trial NCT06802133?
This trial is currently recruiting. The enrollment target is 118 participants. The study started on 2025-01-13. Estimated completion is 2026-07-30.
What conditions does trial NCT06802133 study?
This clinical trial studies the following conditions: Repair of Dura Mater.
What interventions are being tested in trial NCT06802133?
The interventions under investigation include: Post Market Study (OTHER).
Who is sponsoring clinical trial NCT06802133?
This trial is sponsored by Collagen Matrix, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06802133 being conducted?
This trial has 2 study locations across Georgia, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Repair of Dura Mater
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.